Operational Excellence Leading To A Positive Outcome: A Global Phase III Study in Early Alzheimer’s Disease

In a milestone Alzheimer’s Disease study, Worldwide encountered aggressive timeline expectations, multiple protocol amendments, and an unusual adverse event profile. Due to Worldwide’s adaptable, flexible approach, our teams still managed to deliver the study on time and on budget. See how our partnership with the sponsor led to study success.

Your form has been successfully submitted! Click the button below to access.